Role of a clinical pharmacist as part of a multidisciplinary care team in the treatment of HCV in patients living with HIV/HCV coinfection
Integrated Pharmacy Research and Practice2018Vol. Volume 7, pp. 105–111
Citations Over TimeTop 13% of 2018 papers
Abstract
A clinical pharmacist's expertise as part of a multidisciplinary care team facilitates optimal treatment outcomes and provides critical support in the management of DAA therapy in individuals living with HIV/HCV coinfection.
Related Papers
- → Impact of Maternal HIV Coinfection on the Vertical Transmission of Hepatitis C Virus: A Meta-analysis(2007)129 cited
- → Trends for genetic variation of Hepatitis C Virus quasispecies in Human Immunodeficiency virus-1 coinfected patients(2007)16 cited
- → Immunopathogenesis of HIV/Hepatitis C Virus Coinfection(2011)1 cited
- → Analytical and Biological Variables Influencing Quantitative Hepatitis C Virus (HCV) Measurement in HIV-HCV Coinfection(2006)1 cited
- [A study of the progression of cirrhosis in patients with human immunodeficiency virus and hepatitis C virus coinfection].(2005)